1. Home
  2. ACOG vs GEOS Comparison

ACOG vs GEOS Comparison

Compare ACOG & GEOS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ACOG
  • GEOS
  • Stock Information
  • Founded
  • ACOG 2000
  • GEOS 1980
  • Country
  • ACOG Canada
  • GEOS United States
  • Employees
  • ACOG N/A
  • GEOS N/A
  • Industry
  • ACOG
  • GEOS Industrial Machinery/Components
  • Sector
  • ACOG
  • GEOS Industrials
  • Exchange
  • ACOG Nasdaq
  • GEOS Nasdaq
  • Market Cap
  • ACOG 80.3M
  • GEOS 72.9M
  • IPO Year
  • ACOG N/A
  • GEOS 1997
  • Fundamental
  • Price
  • ACOG $9.16
  • GEOS $11.49
  • Analyst Decision
  • ACOG Strong Buy
  • GEOS
  • Analyst Count
  • ACOG 1
  • GEOS 0
  • Target Price
  • ACOG $20.00
  • GEOS N/A
  • AVG Volume (30 Days)
  • ACOG 130.0K
  • GEOS 104.7K
  • Earning Date
  • ACOG 08-14-2025
  • GEOS 08-07-2025
  • Dividend Yield
  • ACOG N/A
  • GEOS N/A
  • EPS Growth
  • ACOG N/A
  • GEOS N/A
  • EPS
  • ACOG N/A
  • GEOS N/A
  • Revenue
  • ACOG $2,928,654.00
  • GEOS $116,542,000.00
  • Revenue This Year
  • ACOG N/A
  • GEOS N/A
  • Revenue Next Year
  • ACOG N/A
  • GEOS N/A
  • P/E Ratio
  • ACOG N/A
  • GEOS N/A
  • Revenue Growth
  • ACOG N/A
  • GEOS N/A
  • 52 Week Low
  • ACOG $3.75
  • GEOS $5.51
  • 52 Week High
  • ACOG $11.40
  • GEOS $13.79
  • Technical
  • Relative Strength Index (RSI)
  • ACOG N/A
  • GEOS 79.75
  • Support Level
  • ACOG N/A
  • GEOS $6.52
  • Resistance Level
  • ACOG N/A
  • GEOS $6.97
  • Average True Range (ATR)
  • ACOG 0.00
  • GEOS 0.69
  • MACD
  • ACOG 0.00
  • GEOS 0.46
  • Stochastic Oscillator
  • ACOG 0.00
  • GEOS 92.30

About ACOG Alpha Cognition Inc. Common Stock

Alpha Cognition Inc is a biopharmaceutical company dedicated to developing treatments for patients suffering from neurodegenerative diseases, such as Alzheimer's disease, for which there are limited or no treatment options. The Company's current focus is on the commercial manufacturing and sales of ZUNVEYL oral tablet formulation. The Company's commercial development program for ZUNVEYL is primarily focused on building a long-term care commercial team that can focus on providing key points of differentiation, exploiting key issues with existing Acetylcholinesterase inhibitors treatments, and seeking potential licensing partners for other additional indications and new formulations.

About GEOS Geospace Technologies Corporation (Texas)

Geospace Technologies Corp is engaged in designing and manufacturing seismic instruments and non-seismic equipment used in the oil and gas industry. The company has three different segments: oil and gas markets, adjacent markets, and emerging markets. The oil and gas markets segment, which accounts for the majority of the company's revenue, includes traditional exploration products, wireless exploration products, and reservoir characterization products and services. The adjacent markets business is closely tied to the oil and gas markets and includes imaging products and industrial products. The company operates globally across Asia, Canada, Europe, the United States, South America, Mexico, and other regions with a majority of its revenue being generated within the United States.

Share on Social Networks: